TBA-354 is a new anti-tuberculosis compound that remains active against Mycobacterium tuberculosis H37RV strain and clinical drug-sensitive and -resistant strains.|TBA-354是新型抗结核化合物,对结核分枝杆菌H37RV菌株和临床药物敏感和耐药的菌株依旧保持活性。 基本信息 更多信息
中文名称:TBA-354是新型抗结核化合物,对结核分枝杆菌H37RV菌株和临床药物敏感和耐药的菌株依旧保持活性。
中文同义词:TBA-354是新型抗结核化合物,对结核分枝杆菌H37RV菌株和临床药物敏感和耐药的菌株依旧保持活性。
英文名称:TBA-354 is a new anti-tuberculosis compound that remains active against Mycobacterium tuberculosis H37RV strain and clinical drug-sensitive and -resistant strains.
英文同义词:TBA-354 is a new anti-tuberculosis compound that remains active against Mycobacterium tuberculosis H37RV strain and clinical drug-sensitive and -resistant strains.
CAS号:
分子式:
分子量:0
EINECS号:
TBA-354 is a new anti-tuberculosis compound that remains active against Mycobacterium tuberculosis H37RV strain and clinical drug-sensitive and -resistant strains.|TBA-354是新型抗结核化合物,对结核分枝杆菌H37RV菌株和临床药物敏感和耐药的菌株依旧保持活性。
信息错误报告
您的Email:
按国家浏览TBA-354 is a new anti-tuberculosis compound that remains active against Mycobacterium tuberculosis H37RV strain and clinical drug-sensitive and -resistant strains.国外供应商 中国供应商
TBA-354 is a new anti-tuberculosis compound that remains active against Mycobacterium tuberculosis H37RV strain and clinical drug-sensitive and -resistant strains. 推荐供应商
建议您优先选择企业会员,我们对企业会员产品有严格审核。
1